Literature DB >> 4065330

Expression of the vasopressin and oxytocin genes in human hypothalami.

E Mohr, M Hillers, R Ivell, I D Haulica, D Richter.   

Abstract

Poly(A)+ RNA isolated from post-mortem human hypothalami has been used to characterize the poly-protein precursors to vasopressin and oxytocin. Translation in a cell-free system and subsequent immuno-precipitation with antibodies raised against either vasopressin or neurophysin identified a product of Mr 19000 (prepro-vasopressin). A second less intense product of Mr 16500 was tentatively identified as prepro-oxytocin. A cDNA library derived from the human hypothalamic poly(A)+ RNA was screened for vasopressin and oxytocin-encoding cDNA using heterologous probes; clones encoding the two precursors were identified and found to be organized as their rat and bovine counterparts. Northern blot analysis shows that the mRNAs for the two prepro-hormones consist of approximately 840 (AVP) and approximately 700 (OT) nucleotides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065330     DOI: 10.1016/0014-5793(85)80069-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.

Authors:  G Mengod; J L Charli; J M Palacios
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

2.  Synthesis of three NH2-terminally extended arginine-vasopressins with prolonged biological activities.

Authors:  B Lammek; P Rekowski; G Kupryszewski; P Melin; U Ragnarsson
Journal:  Experientia       Date:  1987-12-01

3.  Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.

Authors:  M Ito; Y Oiso; T Murase; K Kondo; H Saito; T Chinzei; M Racchi; M O Lively
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

4.  A novel AVP gene mutation in a Turkish family with neurohypophyseal diabetes insipidus.

Authors:  M Ilhan; N O Tiryakioglu; O Karaman; E Coskunpinar; R S Yildiz; S Turgut; D Tiryakioglu; H Toprak; E Tasan
Journal:  J Endocrinol Invest       Date:  2015-07-25       Impact factor: 4.256

5.  Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.

Authors:  S Rittig; G L Robertson; C Siggaard; L Kovács; N Gregersen; J Nyborg; E B Pedersen
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

6.  MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation.

Authors:  David Calligaris; Daniel R Feldman; Isaiah Norton; Olutayo Olubiyi; Armen N Changelian; Revaz Machaidze; Matthew L Vestal; Edward R Laws; Ian F Dunn; Sandro Santagata; Nathalie Y R Agar
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

7.  A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus.

Authors:  U Bahnsen; P Oosting; D F Swaab; P Nahke; D Richter; H Schmale
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.